Drugmaker Pfizer Inc. announced in a press release that early data from its COVID-19 vaccine trial indicates that the vaccine candidate has demonstrated high efficacy. The Phase 3 vaccine candidate's early results were found in an interim analysis by an independent data ...
Read More
0 Comments Click here to read/write comments
Topics: Covid-19-Vaccine, Vaccine-Efficacy, Pfizer
Content not found